Deepak Nitrite Announces Record Q2 & H1 FY27 Results
Deepak Nitrite reported record Q2 FY27 revenue of ₹3,091 crore (up 61% YoY) and EBITDA of ₹643 crore (up 187% YoY). H1 FY27 revenue was ₹5,682 crore (up 48% YoY) with EBITDA at ₹1,197 crore. Phenolics segment achieved record revenue of ₹2,291 crore in Q2. New specialty chemicals plant commissioned with ₹300 crore investment.
The announcement details record financial performance, significant capacity expansions, and strategic project advancements, all of which are material factors for investors and indicate strong future growth potential.
The company reported its best-ever performance with record revenues and EBITDA for both the quarter and half-year, driven by strong performance in the Phenolics segment and successful commissioning of new facilities.
Deepak Nitrite Limited (DNL) announced its Q2 and H1 FY27 earnings, reporting its best-ever performance in operating history. Consolidated revenue from operations for Q2 FY27 reached ₹3,091 crore, a sequential growth of 19% and a year-on-year growth of 61%. EBITDA for the quarter stood at a record ₹643 crore, an 187% year-on-year increase, with EBITDA margins sustained at 21%.
For H1 FY27, consolidated revenue grew by 48% year-on-year to ₹5,682 crore. EBITDA for the half-year increased by 173% to ₹1,197 crore, with margins expanding to 21%. Profit After Tax (PAT) for H1 FY27 reached ₹743 crore, a 221% increase year-on-year.
The Phenolics segment delivered its highest-ever quarterly revenue of ₹2,291 crore, a 72% year-on-year increase, with EBIT of ₹515 crore and an EBIT margin of approximately 22%. For H1 FY27, the segment recorded revenue of ₹4,066 crore and EBIT of ₹933 crore, surpassing the previous highest annual EBIT of ₹867 crore (FY22) in just six months.
The Advanced Intermediates segment reported quarterly revenue of ₹811 crore, a 38% year-on-year growth. EBIT for the quarter was ₹49 crore, with an EBIT margin of 6%. For H1 FY27, revenue reached ₹1,615 crore, and EBIT doubled year-on-year to ₹116 crore. The sequential moderation in profitability was attributed to input price headwinds, customer volume variations, and logistics costs.
New facilities commissioned during the quarter include chlorination, photohalogenation, and a specialty chemicals plant in Dahej with a capital investment of approximately ₹300 crore. The company is progressing with its integrated polycarbonate project, with polycarbonate resin plant commissioning slated for FY29, utilizing bought-out BPA initially.
The company also announced that the transcript of the earnings conference call held on October 30, 2026, for Q2 & H1 FY27 is now available on their website.
What to do with a filing like this
Deepak Nitrite Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Deepak Nitrite Limited. Read the original for the full detail.